Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-6-9
pubmed:abstractText
The mechanisms of phorbol ester- and thrombin-mediated pulmonary artery endothelial barrier dysfunction were compared. Phorbol ester dibutyrate (PDBU) mediated slow force velocity and less force than thrombin. Taxol did not attenuate PDBU-mediated tension, while it reversed nocodazole-mediated tension. PDBU-mediated tension was not affected by acrylamide; PDBU increased cell stiffness and produced greater declines in transendothelial resistance (TER) than acrylamide. Thus PDBU caused a net increase in tension and did not unload microtubule or intermediate filaments. Microfilament remodeling, determined on the basis of immunocytochemistry and actin solubility, lacked the sensitivity and specificity to predict actin-dependent mechanical properties. Thrombin increased myosin light chain (MLC) kinase site-specific MLC phosphorylation, according to peptide map analysis, whereas PDBU did not increase PKC-specific MLC phosphorylation. The initial PDBU-mediated tension development temporally correlated with PDBU-mediated decline in TER and increased low-molecular-weight caldesmon (l-CaD) phosphorylation. PDBU-mediated tension development and decreases in TER were associated with a temporal loss of endothelial cell-matrix adhesion, based on a numerical model of TER. Although, on the basis of immunocytochemistry, thrombin-mediated tension was associated with actin insolubility, actin reorganization, and gap formation, these changes did not predict thrombin-mediated gap formation, based on TER and time-lapse differential interference contrast microscopy. These data suggest that PDBU may disrupt endothelial barrier function through loss of cell-matrix adhesion through l-CaD-dependent actin contraction.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1040-0605
pubmed:author
pubmed:issnType
Print
pubmed:volume
287
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
L153-67
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15003926-Actins, pubmed-meshheading:15003926-Animals, pubmed-meshheading:15003926-Calmodulin-Binding Proteins, pubmed-meshheading:15003926-Capillary Permeability, pubmed-meshheading:15003926-Cells, Cultured, pubmed-meshheading:15003926-Cytoskeleton, pubmed-meshheading:15003926-Endothelium, Vascular, pubmed-meshheading:15003926-Intermediate Filaments, pubmed-meshheading:15003926-Microtubules, pubmed-meshheading:15003926-Molecular Weight, pubmed-meshheading:15003926-Myosin Light Chains, pubmed-meshheading:15003926-Phorbol 12,13-Dibutyrate, pubmed-meshheading:15003926-Phosphorylation, pubmed-meshheading:15003926-Pulmonary Artery, pubmed-meshheading:15003926-Swine, pubmed-meshheading:15003926-Thrombin, pubmed-meshheading:15003926-Time Factors, pubmed-meshheading:15003926-Vascular Resistance, pubmed-meshheading:15003926-Vasoconstriction
pubmed:year
2004
pubmed:articleTitle
Phorbol ester-mediated pulmonary artery endothelial barrier dysfunction through regulation of actin cytoskeletal mechanics.
pubmed:affiliation
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, 52242, USA. alan-moy@uiowa.edu
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't